RecruitingNot ApplicableNCT07000604

Effect of ınhaler Use on Oral Health in COPD Patients

Effect of Inhaler Medication Use on Oral Health in COPD Patients: A Randomized Controlled Trial

Sponsor

Çankırı Karatekin University

Enrollment

80 participants

Start Date

May 30, 2025

Study Type

INTERVENTIONAL

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Summary

The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.

Eligibility

Min Age: 35 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how using a metered dose inhaler (MDI) — the kind of pump inhaler used to treat COPD — affects the health of your teeth and gums over time. **You may be eligible if...** - You have been diagnosed with COPD for at least 6 months - You use a metered dose inhaler (MDI) as part of your treatment - You are 18 or older - You do not currently have a COPD flare-up or active respiratory infection - Your COPD is mild, moderate, or severe (Stage 1–3 per GOLD guidelines) **You may NOT be eligible if...** - You have had COPD for less than 6 months - You do not use a metered dose inhaler - You are currently having a COPD flare-up or respiratory infection - You are unable to communicate or declined to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.